In September, Stryker announced plans to acquire the company for $190 million, or $7.40 per share. The acquisition is expected to have an immaterial impact on Stryker’s net earnings in 2018.
Invuity develops photonics and single-use, lighted instruments to enhance visualization for a wide variety of clinical applications, including orthopedic and spine surgery.
More articles on devices and implants:
Intuitive Surgical records $921M in Q3 revenue: 3 things to know
Stryker extends $1.4B K2M acquisition deadline: 5 key points
Global spine surgery devices market to reach $2.98B by 2022 –– 9 key companies
